Home >> Law >> Food & Beverage >>

Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2015

Published: May-2015 | Format: PDF | Global Markets Direct | Number of pages: 18 | Code: MRS - 19830

Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2015’, provides an overview of the Arbor Pharmaceuticals, LLC.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Arbor Pharmaceuticals, LLC.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Arbor Pharmaceuticals, LLC. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Arbor Pharmaceuticals, LLC.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Arbor Pharmaceuticals, LLC.’s pipeline products

Reasons to buy

- Evaluate Arbor Pharmaceuticals, LLC.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Arbor Pharmaceuticals, LLC. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Arbor Pharmaceuticals, LLC.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Arbor Pharmaceuticals, LLC. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Arbor Pharmaceuticals, LLC.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Arbor Pharmaceuticals, LLC. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Arbor Pharmaceuticals, LLC. Snapshot 4
Arbor Pharmaceuticals, LLC. Overview 4
Key Information 4
Key Facts 4
Arbor Pharmaceuticals, LLC. - Research and Development Overview 5
Key Therapeutic Areas 5
Arbor Pharmaceuticals, LLC. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Arbor Pharmaceuticals, LLC. - Pipeline Products Glance 9
Arbor Pharmaceuticals, LLC. - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Arbor Pharmaceuticals, LLC. - Drug Profiles 11
AR-08 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
AR-06 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
AR-18 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Arbor Pharmaceuticals, LLC. - Pipeline Analysis 14
Arbor Pharmaceuticals, LLC. - Pipeline Products by Route of Administration 14
Arbor Pharmaceuticals, LLC. - Recent Pipeline Updates 15
Arbor Pharmaceuticals, LLC. - Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
Coverage 17
Secondary Research 17
Primary Research 17
Expert Panel Validation 17
Contact Us 17
Disclaimer 18

List of Tables
Arbor Pharmaceuticals, LLC., Key Information 4
Arbor Pharmaceuticals, LLC., Key Facts 4
Arbor Pharmaceuticals, LLC. - Pipeline by Indication, 2015 6
Arbor Pharmaceuticals, LLC. - Pipeline by Stage of Development, 2015 7
Arbor Pharmaceuticals, LLC. - Monotherapy Products in Pipeline, 2015 8
Arbor Pharmaceuticals, LLC. - Phase II, 2015 9
Arbor Pharmaceuticals, LLC. - Phase I, 2015 10
Arbor Pharmaceuticals, LLC. - Pipeline by Route of Administration, 2015 14
Arbor Pharmaceuticals, LLC. - Recent Pipeline Updates, 2015 15

List of Figures
Arbor Pharmaceuticals, LLC. - Pipeline by Top 10 Indication, 2015 6
Arbor Pharmaceuticals, LLC. - Pipeline by Stage of Development, 2015 7
Arbor Pharmaceuticals, LLC. - Monotherapy Products in Pipeline, 2015 8

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)1500 View Pricing